Old Web
English
Sign In
Acemap
>
authorDetail
>
Lorenza Landi
Lorenza Landi
Medicine
Sorafenib
Sunitinib
Renal cell carcinoma
Urology
4
Papers
178
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
2013
British Journal of Cancer
Vittoria Martin
Lorenza Landi
Francesca Molinari
G. Fountzilas
R. Geva
Alice Riva
Piercarlo Saletti
S De Dosso
Alessandra Spitale
Sabine Tejpar
Konstantine T. Kalogeras
Luca Mazzucchelli
Milo Frattini
Federico Cappuzzo
Show All
Source
Cite
Save
Citations (102)
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases: SEQUENTIAL USE OF SORAFENIB AND SUNITINIB IN ADVANCED RCC
2011
BJUI
Camillo Porta
Giuseppe Procopio
Giacomo Carteni
Roberto Sabbatini
Alessandra Bearz
Isabella Chiappino
Enzo Maria Ruggeri
Giovanni Lo Re
Riccardo Ricotta
Fable Zustovich
Lorenza Landi
Anna Calcagno
Ilaria Imarisio
Elena Verzoni
Mimma Rizzo
Chiara Paglino
Valentina Guadalupi
Emilio Bajetta
Show All
Source
Cite
Save
Citations (0)
Sequential use of sorafenib and sunitinib in advanced renal‐cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases
2011
BJUI
Camillo Porta
Giuseppe Procopio
Giacomo Cartenì
Roberto Sabbatini
Alessandra Bearz
Isabella Chiappino
Enzo Maria Ruggeri
Giovanni Lo Re
Riccardo Ricotta
Fable Zustovich
Lorenza Landi
Anna Calcagno
Ilaria Imarisio
Elena Verzoni
Mimma Rizzo
Chiara Paglino
Valentina Guadalupi
Emilio Bajetta
Show All
Source
Cite
Save
Citations (76)
1